Pandemic influenza A (H1N1) 2009 : the experience of the first six months

Simple item page
dc.contributor.authorMaritz, Jean
dc.contributor.authorMaree, Leana
dc.contributor.authorPreiser, Wolfgang
dc.contributor.otherSouth African National Institute of Communicable Diseases for subtyping of influenza A strains.
dc.date.accessioned2010-11-02T11:39:26Z
dc.date.available2010-11-02T11:39:26Z
dc.date.issued2010-04
dc.descriptionIncludes bibliography
dc.description.abstractAfter a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel.en_ZA
dc.format.extent10 p. : col. ill.
dc.identifier.citationMaritz, J, Maree, L & Preiser, W 2010, 'Pandemic influenza A (H1N1) 2009: the experience of the first six months', Clinical Chemistry and Laboratory Medicine, vol. 48, issue 1, pp. 11-21, http://www.reference-global.com/, DOI: 10.1515/CCLM.2010.023en_ZA
dc.identifier.issn1434-6621 (print)
dc.identifier.issn1437-4331 (online)
dc.identifier.other10.1515/CCLM.2010.023
dc.identifier.urihttp://hdl.handle.net/10019.1/4850
dc.language.isoen_ZAen_ZA
dc.publisherWalter de Gruyteren_ZA
dc.rights.holderWalter de Gruyteren_ZA
dc.subjectAge distributionen_ZA
dc.subjectDisease outbreaksen_ZA
dc.subjectInfluenza A Virusen_ZA
dc.subjectH1N1 Subtypeen_ZA
dc.subjectInfluenza Vaccines/therapeutic useen_ZA
dc.subjectSurvival rateen_ZA
dc.subjectInfluenza vaccinesen_ZA
dc.subjectAntiviral Agents therapeutic useen_ZA
dc.subjectHuman epidemiologyen_ZA
dc.subjectHuman virologyen_ZA
dc.subjectSwine flu
dc.subject.lcshSwine influenza -- Treatment -- Researchen_ZA
dc.subject.lcshAntiviral agents -- Researchen_ZA
dc.subject.lcshAntiviral agents -- Therapeutic useen_ZA
dc.titlePandemic influenza A (H1N1) 2009 : the experience of the first six monthsen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
maritz_pandemic_2010.pdf
Size:
199.55 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Medical Virology)